HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Ayres Selected Research

Prodrugs

4/2001Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Ayres Research Topics

Disease

1Brain Injuries (Brain Injury)
01/2010
1Multiple Myeloma
07/2001
1Neoplasms (Cancer)
04/2001
1Hematologic Neoplasms (Hematological Malignancy)
04/2001
1Leukemia
04/2001

Drug/Important Bio-Agent (IBA)

18-chloro-cyclic adenosine monophosphateIBA
07/2001
1nelarabine (506U78)FDA Link
04/2001
1triphosphoric acid (triphosphate)IBA
04/2001
1ProdrugsIBA
04/2001
19-beta-D-arabinofuranosylguanosine 5'-triphosphateIBA
04/2001
1fludarabineIBA
04/2001
19-arabinofuranosylguanineIBA
04/2001

Therapy/Procedure

1Resistance Training
01/2010
1Therapeutics
04/2001